Noveris Health Sciences is trading 6.7% up at CA$0.08 on October 8, 2026, with no clear company-specific catalyst identified.
- The broader market is weak, but that does not explain the stock’s upward move; biotech weakness is also not a matching-direction explanation.
- The latest company news located was its September 9 AGM results.